Balchem (BCPC) Stock Overview
Develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
BCPC passed our risk checks.
BCPC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
An Undervalued 3.3Moz Gold Project in Canada
Key takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read more
Balchem Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$180.29 |
| 52 Week High | US$183.01 |
| 52 Week Low | US$139.17 |
| Beta | 0.95 |
| 1 Month Change | 8.54% |
| 3 Month Change | 15.42% |
| 1 Year Change | 4.82% |
| 3 Year Change | 37.46% |
| 5 Year Change | 48.13% |
| Change since IPO | 71,956.63% |
Recent News & Updates
Encapsulation Investments And International Expansion Will Shape Balanced Future For Nutrition Specialist
Catalysts About Balchem Balchem produces specialty nutrition and ingredient solutions for human, animal and plant health, along with performance gases. What are the underlying business or industry changes driving this perspective?If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity
Feb 15
Recent updates
Encapsulation Investments And International Expansion Will Shape Balanced Future For Nutrition Specialist
Catalysts About Balchem Balchem produces specialty nutrition and ingredient solutions for human, animal and plant health, along with performance gases. What are the underlying business or industry changes driving this perspective?If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity
Feb 15Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?
Feb 01Balchem: A Healthier Assessment
Jan 08Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital
Dec 01Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio
Oct 10Balchem (NASDAQ:BCPC) Could Easily Take On More Debt
Sep 26Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Aug 26Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital
Jul 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely
Jun 23When Should You Buy Balchem Corporation (NASDAQ:BCPC)?
May 26Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
May 12Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?
Apr 17We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease
Mar 21Balchem Corporation (NASDAQ:BCPC) Not Lagging Market On Growth Or Pricing
Mar 07Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28
Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion
Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.Balchem: A Tale Of Two Businesses
May 10Balchem: Potential Turnaround Is In The Price
Feb 21Shareholder Returns
| BCPC | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 3.0% | 0.7% | 0.6% |
| 1Y | 4.8% | 3.8% | 18.4% |
Return vs Industry: BCPC matched the US Chemicals industry which returned 4% over the past year.
Return vs Market: BCPC underperformed the US Market which returned 17.5% over the past year.
Price Volatility
| BCPC volatility | |
|---|---|
| BCPC Average Weekly Movement | 3.3% |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BCPC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BCPC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,352 | Ted Harris | www.balchem.com |
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Balchem Corporation Fundamentals Summary
| BCPC fundamental statistics | |
|---|---|
| Market cap | US$5.75b |
| Earnings (TTM) | US$154.85m |
| Revenue (TTM) | US$1.04b |
Is BCPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BCPC income statement (TTM) | |
|---|---|
| Revenue | US$1.04b |
| Cost of Revenue | US$666.53m |
| Gross Profit | US$370.63m |
| Other Expenses | US$215.79m |
| Earnings | US$154.85m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.84 |
| Gross Margin | 35.74% |
| Net Profit Margin | 14.93% |
| Debt/Equity Ratio | 13.0% |
How did BCPC perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/26 15:05 |
| End of Day Share Price | 2026/02/26 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Balchem Corporation is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Labick | CJS Securities, Inc. |
| Timothy Ramey | D.A. Davidson & Co. |
| Raghuram Selvaraju | H.C. Wainwright & Co. |